| abstract |
The present document discloses a drug delivery device for wearing since it includes a container at least partially loaded with a drug that includes at least one of a specific antibody of PCSK9 (Subtilisin Convertase / Kexin Type 9 Proprotein), a stimulating factor of granulocyte colonies (G-CSF) sclerostin, or a peptide antibody related to the calcitonin gene (CGRP). Said device may include a needle and an insertion mechanism configured to insert the needle into a patient. |